It is organized by the International Network for Hepatitis in Substance Users (INHSU). The symposium is held biennially and was first held in Zurich, Switzerland, in 2009, Brussels, Belgium, in 2011, Munich, Germany, in 2013 and Sydney, Australia, in 2015. In 2015, INHSU decided to move to an annual symposium to keep pace with the rapid development of new therapies and exciting new research on HCV care among people who inject drugs. Hence, the 2016 INHSU symposium was held in Oslo, Norway ,in 2017 Jersey City, United States and in 2018 the symposium will be held in Cascais, Portugal.
The International Symposium on Hepatitis in Substance Users attracts delegates including health professionals (doctors, nurses and allied health), researchers, community organisations, people who use drugs and policy makers.
Programme topics to include:
Day 1: Epidemiology, Public Health, Prevention and Harm Reduction
Day 2: HCV diagnosis, linkage to care and treatment
Day 3: Achieving HCV Elimination
For more information on the International Network on Hepatitis in Substance Users please visit the website www.inhsu.org